Abstract
Because Alzheimer's disease (AD) is a medical problem characterized by progressive loss of memory and cognition that is associated with a deficient cholinergic system, this work aims to evaluate some p-aminobenzoic acid (PABA) derivatives as acetylcholinesterase inhibitors in vitro, in continuation with our last studies. The assayed compounds are low toxic, simple-structured and low cost.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
4-Aminobenzoic Acid / chemical synthesis*
-
4-Aminobenzoic Acid / pharmacology
-
Acetylcholinesterase / drug effects
-
Alzheimer Disease / drug therapy
-
Animals
-
Binding Sites
-
Cattle
-
Cholinesterase Inhibitors / chemical synthesis*
-
Cholinesterase Inhibitors / pharmacology
-
Models, Molecular
Substances
-
Cholinesterase Inhibitors
-
Acetylcholinesterase
-
4-Aminobenzoic Acid